Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics

Decision-analytic modeling studies: An overview for clinicians using multiple myeloma as an example

(2015) U. Rochau et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

(2013) Sean D. Sullivan et al.   VALUE IN HEALTH

Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

(2012) Andrew H. Briggs et al.   VALUE IN HEALTH

Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2

(2012) Mark Roberts et al.   VALUE IN HEALTH

State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3

(2012) Uwe Siebert et al.   VALUE IN HEALTH

Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7

(2012) David M. Eddy et al.   VALUE IN HEALTH

The split system approach to managing time in simulations of hybrid systems having continuous and discrete event components

(2011) James Nutaro et al.   SIMULATION-TRANSACTIONS OF THE SOCIETY FOR MODELING AND SIMULATION INTERNATIONAL

Modelling Methods for Pharmacoeconomics and Health Technology Assessment

(2009) James E Stahl   PHARMACOECONOMICS